nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Estradiol—osteoporosis	0.201	0.302	CbGbCtD
Indacaterol—ABCB1—Ethinyl Estradiol—osteoporosis	0.062	0.093	CbGbCtD
Indacaterol—CYP3A4—Estropipate—osteoporosis	0.0576	0.0865	CbGbCtD
Indacaterol—CYP3A4—Calcitriol—osteoporosis	0.0576	0.0865	CbGbCtD
Indacaterol—CYP3A4—Ergocalciferol—osteoporosis	0.0461	0.0691	CbGbCtD
Indacaterol—ABCB1—Conjugated Estrogens—osteoporosis	0.0455	0.0682	CbGbCtD
Indacaterol—ABCB1—Estradiol—osteoporosis	0.0399	0.0599	CbGbCtD
Indacaterol—CYP3A4—Raloxifene—osteoporosis	0.0385	0.0577	CbGbCtD
Indacaterol—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0371	0.0557	CbGbCtD
Indacaterol—CYP3A4—Cholecalciferol—osteoporosis	0.0297	0.0445	CbGbCtD
Indacaterol—CYP3A4—Conjugated Estrogens—osteoporosis	0.0273	0.0409	CbGbCtD
Indacaterol—CYP3A4—Estradiol—osteoporosis	0.0239	0.0359	CbGbCtD
Indacaterol—Infestation—Zoledronate—osteoporosis	0.000877	0.00265	CcSEcCtD
Indacaterol—Infestation NOS—Zoledronate—osteoporosis	0.000877	0.00265	CcSEcCtD
Indacaterol—Cough—Estropipate—osteoporosis	0.000871	0.00264	CcSEcCtD
Indacaterol—Vertigo—Raloxifene—osteoporosis	0.000869	0.00263	CcSEcCtD
Indacaterol—Vertigo—Ibandronate—osteoporosis	0.00086	0.0026	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000858	0.0026	CcSEcCtD
Indacaterol—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000854	0.00258	CcSEcCtD
Indacaterol—Nausea—Calcium Acetate—osteoporosis	0.000852	0.00258	CcSEcCtD
Indacaterol—Myalgia—Estropipate—osteoporosis	0.00085	0.00257	CcSEcCtD
Indacaterol—Connective tissue disorder—Pamidronate—osteoporosis	0.000847	0.00256	CcSEcCtD
Indacaterol—Palpitations—Ibandronate—osteoporosis	0.000846	0.00256	CcSEcCtD
Indacaterol—Paraesthesia—Etidronic acid—osteoporosis	0.000846	0.00256	CcSEcCtD
Indacaterol—Infestation NOS—Conjugated Estrogens—osteoporosis	0.000844	0.00255	CcSEcCtD
Indacaterol—Infestation—Conjugated Estrogens—osteoporosis	0.000844	0.00255	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000844	0.00255	CcSEcCtD
Indacaterol—Cough—Raloxifene—osteoporosis	0.000844	0.00255	CcSEcCtD
Indacaterol—Cardiac disorder—Risedronate—osteoporosis	0.000841	0.00255	CcSEcCtD
Indacaterol—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00084	0.00254	CcSEcCtD
Indacaterol—Myalgia—Alendronate—osteoporosis	0.000837	0.00253	CcSEcCtD
Indacaterol—Chest pain—Alendronate—osteoporosis	0.000837	0.00253	CcSEcCtD
Indacaterol—Myalgia—Raloxifene—osteoporosis	0.000823	0.00249	CcSEcCtD
Indacaterol—Chest pain—Raloxifene—osteoporosis	0.000823	0.00249	CcSEcCtD
Indacaterol—Immune system disorder—Risedronate—osteoporosis	0.000819	0.00248	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000818	0.00247	CcSEcCtD
Indacaterol—Mediastinal disorder—Risedronate—osteoporosis	0.000817	0.00247	CcSEcCtD
Indacaterol—Chest pain—Ibandronate—osteoporosis	0.000815	0.00247	CcSEcCtD
Indacaterol—Myalgia—Ibandronate—osteoporosis	0.000815	0.00247	CcSEcCtD
Indacaterol—Infection—Estropipate—osteoporosis	0.000809	0.00245	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000809	0.00245	CcSEcCtD
Indacaterol—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000809	0.00245	CcSEcCtD
Indacaterol—Cardiac disorder—Pamidronate—osteoporosis	0.0008	0.00242	CcSEcCtD
Indacaterol—Nervous system disorder—Estropipate—osteoporosis	0.000799	0.00242	CcSEcCtD
Indacaterol—Myalgia—Calcitriol—osteoporosis	0.000798	0.00241	CcSEcCtD
Indacaterol—Chest pain—Calcitriol—osteoporosis	0.000798	0.00241	CcSEcCtD
Indacaterol—Infection—Alendronate—osteoporosis	0.000797	0.00241	CcSEcCtD
Indacaterol—Dry mouth—Ibandronate—osteoporosis	0.000797	0.00241	CcSEcCtD
Indacaterol—Sinusitis—Conjugated Estrogens—osteoporosis	0.000792	0.0024	CcSEcCtD
Indacaterol—Skin disorder—Estropipate—osteoporosis	0.000791	0.00239	CcSEcCtD
Indacaterol—Malnutrition—Risedronate—osteoporosis	0.000789	0.00239	CcSEcCtD
Indacaterol—Infection—Raloxifene—osteoporosis	0.000784	0.00237	CcSEcCtD
Indacaterol—Nasopharyngitis—Estradiol—osteoporosis	0.000784	0.00237	CcSEcCtD
Indacaterol—Dry mouth—Calcitriol—osteoporosis	0.00078	0.00236	CcSEcCtD
Indacaterol—Immune system disorder—Pamidronate—osteoporosis	0.000778	0.00235	CcSEcCtD
Indacaterol—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000778	0.00235	CcSEcCtD
Indacaterol—Mediastinal disorder—Pamidronate—osteoporosis	0.000776	0.00235	CcSEcCtD
Indacaterol—Infection—Ibandronate—osteoporosis	0.000776	0.00235	CcSEcCtD
Indacaterol—Oedema peripheral—Zoledronate—osteoporosis	0.000775	0.00235	CcSEcCtD
Indacaterol—Nervous system disorder—Raloxifene—osteoporosis	0.000774	0.00234	CcSEcCtD
Indacaterol—Connective tissue disorder—Zoledronate—osteoporosis	0.000773	0.00234	CcSEcCtD
Indacaterol—Skin disorder—Raloxifene—osteoporosis	0.000767	0.00232	CcSEcCtD
Indacaterol—Nervous system disorder—Ibandronate—osteoporosis	0.000766	0.00232	CcSEcCtD
Indacaterol—Skin disorder—Ibandronate—osteoporosis	0.000759	0.0023	CcSEcCtD
Indacaterol—Muscle spasms—Risedronate—osteoporosis	0.000759	0.0023	CcSEcCtD
Indacaterol—Asthma—Estradiol—osteoporosis	0.000758	0.00229	CcSEcCtD
Indacaterol—Nausea—Ergocalciferol—osteoporosis	0.000753	0.00228	CcSEcCtD
Indacaterol—Malnutrition—Pamidronate—osteoporosis	0.00075	0.00227	CcSEcCtD
Indacaterol—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000746	0.00226	CcSEcCtD
Indacaterol—Bronchospasm—Estradiol—osteoporosis	0.000745	0.00226	CcSEcCtD
Indacaterol—Skin disorder—Calcitriol—osteoporosis	0.000743	0.00225	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000742	0.00225	CcSEcCtD
Indacaterol—Paraesthesia—Estropipate—osteoporosis	0.000732	0.00221	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000731	0.00221	CcSEcCtD
Indacaterol—Cardiac disorder—Zoledronate—osteoporosis	0.00073	0.00221	CcSEcCtD
Indacaterol—Anaemia—Risedronate—osteoporosis	0.000729	0.00221	CcSEcCtD
Indacaterol—Muscle spasms—Pamidronate—osteoporosis	0.000721	0.00218	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000719	0.00218	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000712	0.00215	CcSEcCtD
Indacaterol—Immune system disorder—Zoledronate—osteoporosis	0.000711	0.00215	CcSEcCtD
Indacaterol—Mediastinal disorder—Zoledronate—osteoporosis	0.000709	0.00215	CcSEcCtD
Indacaterol—Vertigo—Risedronate—osteoporosis	0.000709	0.00214	CcSEcCtD
Indacaterol—Cough—Ethinyl Estradiol—osteoporosis	0.000706	0.00214	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Estradiol—osteoporosis	0.000704	0.00213	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Estropipate—osteoporosis	0.000703	0.00213	CcSEcCtD
Indacaterol—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000703	0.00213	CcSEcCtD
Indacaterol—Paraesthesia—Ibandronate—osteoporosis	0.000702	0.00212	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000697	0.00211	CcSEcCtD
Indacaterol—Hypersensitivity—Etidronic acid—osteoporosis	0.000694	0.0021	CcSEcCtD
Indacaterol—Anaemia—Pamidronate—osteoporosis	0.000693	0.0021	CcSEcCtD
Indacaterol—Cough—Risedronate—osteoporosis	0.000688	0.00208	CcSEcCtD
Indacaterol—Malnutrition—Zoledronate—osteoporosis	0.000685	0.00207	CcSEcCtD
Indacaterol—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000684	0.00207	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000684	0.00207	CcSEcCtD
Indacaterol—Hyperglycaemia—Estradiol—osteoporosis	0.000683	0.00207	CcSEcCtD
Indacaterol—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000683	0.00207	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000681	0.00206	CcSEcCtD
Indacaterol—Pneumonia—Estradiol—osteoporosis	0.000679	0.00206	CcSEcCtD
Indacaterol—Infestation NOS—Estradiol—osteoporosis	0.000676	0.00204	CcSEcCtD
Indacaterol—Infestation—Estradiol—osteoporosis	0.000676	0.00204	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000675	0.00204	CcSEcCtD
Indacaterol—Chest pain—Risedronate—osteoporosis	0.000672	0.00203	CcSEcCtD
Indacaterol—Myalgia—Risedronate—osteoporosis	0.000672	0.00203	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000667	0.00202	CcSEcCtD
Indacaterol—Pruritus—Etidronic acid—osteoporosis	0.000666	0.00202	CcSEcCtD
Indacaterol—Malnutrition—Conjugated Estrogens—osteoporosis	0.00066	0.002	CcSEcCtD
Indacaterol—Muscle spasms—Zoledronate—osteoporosis	0.000659	0.00199	CcSEcCtD
Indacaterol—Dry mouth—Risedronate—osteoporosis	0.000657	0.00199	CcSEcCtD
Indacaterol—Infection—Ethinyl Estradiol—osteoporosis	0.000656	0.00199	CcSEcCtD
Indacaterol—Cough—Pamidronate—osteoporosis	0.000654	0.00198	CcSEcCtD
Indacaterol—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000648	0.00196	CcSEcCtD
Indacaterol—Tremor—Zoledronate—osteoporosis	0.000642	0.00194	CcSEcCtD
Indacaterol—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000641	0.00194	CcSEcCtD
Indacaterol—Infection—Risedronate—osteoporosis	0.00064	0.00194	CcSEcCtD
Indacaterol—Myalgia—Pamidronate—osteoporosis	0.000639	0.00193	CcSEcCtD
Indacaterol—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000634	0.00192	CcSEcCtD
Indacaterol—Sinusitis—Estradiol—osteoporosis	0.000634	0.00192	CcSEcCtD
Indacaterol—Anaemia—Zoledronate—osteoporosis	0.000633	0.00192	CcSEcCtD
Indacaterol—Nervous system disorder—Risedronate—osteoporosis	0.000631	0.00191	CcSEcCtD
Indacaterol—Skin disorder—Risedronate—osteoporosis	0.000625	0.00189	CcSEcCtD
Indacaterol—Vertigo—Zoledronate—osteoporosis	0.000615	0.00186	CcSEcCtD
Indacaterol—Infection—Pamidronate—osteoporosis	0.000608	0.00184	CcSEcCtD
Indacaterol—Palpitations—Zoledronate—osteoporosis	0.000605	0.00183	CcSEcCtD
Indacaterol—Hypersensitivity—Estropipate—osteoporosis	0.0006	0.00182	CcSEcCtD
Indacaterol—Nervous system disorder—Pamidronate—osteoporosis	0.0006	0.00182	CcSEcCtD
Indacaterol—Cough—Zoledronate—osteoporosis	0.000598	0.00181	CcSEcCtD
Indacaterol—Oedema peripheral—Estradiol—osteoporosis	0.000597	0.00181	CcSEcCtD
Indacaterol—Tachycardia—Pamidronate—osteoporosis	0.000597	0.00181	CcSEcCtD
Indacaterol—Connective tissue disorder—Estradiol—osteoporosis	0.000596	0.0018	CcSEcCtD
Indacaterol—Rash—Etidronic acid—osteoporosis	0.000594	0.0018	CcSEcCtD
Indacaterol—Dermatitis—Etidronic acid—osteoporosis	0.000593	0.0018	CcSEcCtD
Indacaterol—Vertigo—Conjugated Estrogens—osteoporosis	0.000593	0.00179	CcSEcCtD
Indacaterol—Hypersensitivity—Alendronate—osteoporosis	0.000591	0.00179	CcSEcCtD
Indacaterol—Headache—Etidronic acid—osteoporosis	0.00059	0.00179	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000587	0.00178	CcSEcCtD
Indacaterol—Chest pain—Zoledronate—osteoporosis	0.000583	0.00176	CcSEcCtD
Indacaterol—Myalgia—Zoledronate—osteoporosis	0.000583	0.00176	CcSEcCtD
Indacaterol—Palpitations—Conjugated Estrogens—osteoporosis	0.000583	0.00176	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000579	0.00175	CcSEcCtD
Indacaterol—Paraesthesia—Risedronate—osteoporosis	0.000578	0.00175	CcSEcCtD
Indacaterol—Pruritus—Estropipate—osteoporosis	0.000576	0.00174	CcSEcCtD
Indacaterol—Hypersensitivity—Ibandronate—osteoporosis	0.000576	0.00174	CcSEcCtD
Indacaterol—Cough—Conjugated Estrogens—osteoporosis	0.000576	0.00174	CcSEcCtD
Indacaterol—Dyspnoea—Risedronate—osteoporosis	0.000574	0.00174	CcSEcCtD
Indacaterol—Dry mouth—Zoledronate—osteoporosis	0.00057	0.00173	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00057	0.00173	CcSEcCtD
Indacaterol—Pruritus—Alendronate—osteoporosis	0.000568	0.00172	CcSEcCtD
Indacaterol—Hypersensitivity—Calcitriol—osteoporosis	0.000563	0.00171	CcSEcCtD
Indacaterol—Cardiac disorder—Estradiol—osteoporosis	0.000563	0.0017	CcSEcCtD
Indacaterol—Chest pain—Conjugated Estrogens—osteoporosis	0.000562	0.0017	CcSEcCtD
Indacaterol—Myalgia—Conjugated Estrogens—osteoporosis	0.000562	0.0017	CcSEcCtD
Indacaterol—Nausea—Etidronic acid—osteoporosis	0.000559	0.00169	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000558	0.00169	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000558	0.00169	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Risedronate—osteoporosis	0.000556	0.00168	CcSEcCtD
Indacaterol—Infection—Zoledronate—osteoporosis	0.000555	0.00168	CcSEcCtD
Indacaterol—Pruritus—Ibandronate—osteoporosis	0.000553	0.00167	CcSEcCtD
Indacaterol—Paraesthesia—Pamidronate—osteoporosis	0.00055	0.00166	CcSEcCtD
Indacaterol—Nervous system disorder—Zoledronate—osteoporosis	0.000548	0.00166	CcSEcCtD
Indacaterol—Immune system disorder—Estradiol—osteoporosis	0.000548	0.00166	CcSEcCtD
Indacaterol—Mediastinal disorder—Estradiol—osteoporosis	0.000547	0.00165	CcSEcCtD
Indacaterol—Dyspnoea—Pamidronate—osteoporosis	0.000546	0.00165	CcSEcCtD
Indacaterol—Tachycardia—Zoledronate—osteoporosis	0.000546	0.00165	CcSEcCtD
Indacaterol—Skin disorder—Zoledronate—osteoporosis	0.000543	0.00164	CcSEcCtD
Indacaterol—Pruritus—Calcitriol—osteoporosis	0.000541	0.00164	CcSEcCtD
Indacaterol—Dizziness—Estropipate—osteoporosis	0.000539	0.00163	CcSEcCtD
Indacaterol—Infection—Conjugated Estrogens—osteoporosis	0.000535	0.00162	CcSEcCtD
Indacaterol—Dizziness—Alendronate—osteoporosis	0.000531	0.00161	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000528	0.0016	CcSEcCtD
Indacaterol—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000528	0.0016	CcSEcCtD
Indacaterol—Malnutrition—Estradiol—osteoporosis	0.000528	0.0016	CcSEcCtD
Indacaterol—Tachycardia—Conjugated Estrogens—osteoporosis	0.000525	0.00159	CcSEcCtD
Indacaterol—Skin disorder—Conjugated Estrogens—osteoporosis	0.000523	0.00158	CcSEcCtD
Indacaterol—Dizziness—Raloxifene—osteoporosis	0.000522	0.00158	CcSEcCtD
Indacaterol—Dizziness—Ibandronate—osteoporosis	0.000517	0.00156	CcSEcCtD
Indacaterol—Rash—Estropipate—osteoporosis	0.000514	0.00155	CcSEcCtD
Indacaterol—Dermatitis—Estropipate—osteoporosis	0.000513	0.00155	CcSEcCtD
Indacaterol—Headache—Estropipate—osteoporosis	0.00051	0.00154	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000509	0.00154	CcSEcCtD
Indacaterol—Muscle spasms—Estradiol—osteoporosis	0.000508	0.00154	CcSEcCtD
Indacaterol—Rash—Alendronate—osteoporosis	0.000506	0.00153	CcSEcCtD
Indacaterol—Dermatitis—Alendronate—osteoporosis	0.000506	0.00153	CcSEcCtD
Indacaterol—Headache—Alendronate—osteoporosis	0.000503	0.00152	CcSEcCtD
Indacaterol—Paraesthesia—Zoledronate—osteoporosis	0.000502	0.00152	CcSEcCtD
Indacaterol—Dyspnoea—Zoledronate—osteoporosis	0.000498	0.00151	CcSEcCtD
Indacaterol—Rash—Raloxifene—osteoporosis	0.000498	0.00151	CcSEcCtD
Indacaterol—Dermatitis—Raloxifene—osteoporosis	0.000497	0.0015	CcSEcCtD
Indacaterol—Tremor—Estradiol—osteoporosis	0.000495	0.0015	CcSEcCtD
Indacaterol—Headache—Raloxifene—osteoporosis	0.000494	0.0015	CcSEcCtD
Indacaterol—Rash—Ibandronate—osteoporosis	0.000493	0.00149	CcSEcCtD
Indacaterol—Dermatitis—Ibandronate—osteoporosis	0.000492	0.00149	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00049	0.00148	CcSEcCtD
Indacaterol—Headache—Ibandronate—osteoporosis	0.000489	0.00148	CcSEcCtD
Indacaterol—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000487	0.00147	CcSEcCtD
Indacaterol—Nausea—Estropipate—osteoporosis	0.000484	0.00146	CcSEcCtD
Indacaterol—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000483	0.00146	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000483	0.00146	CcSEcCtD
Indacaterol—Rash—Calcitriol—osteoporosis	0.000482	0.00146	CcSEcCtD
Indacaterol—Dermatitis—Calcitriol—osteoporosis	0.000482	0.00146	CcSEcCtD
Indacaterol—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00048	0.00145	CcSEcCtD
Indacaterol—Headache—Calcitriol—osteoporosis	0.000479	0.00145	CcSEcCtD
Indacaterol—Nausea—Alendronate—osteoporosis	0.000477	0.00144	CcSEcCtD
Indacaterol—Hypersensitivity—Risedronate—osteoporosis	0.000474	0.00144	CcSEcCtD
Indacaterol—Vertigo—Estradiol—osteoporosis	0.000474	0.00144	CcSEcCtD
Indacaterol—Nausea—Raloxifene—osteoporosis	0.000469	0.00142	CcSEcCtD
Indacaterol—Pruritus—Ethinyl Estradiol—osteoporosis	0.000467	0.00141	CcSEcCtD
Indacaterol—Palpitations—Estradiol—osteoporosis	0.000467	0.00141	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000465	0.00141	CcSEcCtD
Indacaterol—Nausea—Ibandronate—osteoporosis	0.000464	0.0014	CcSEcCtD
Indacaterol—Cough—Estradiol—osteoporosis	0.000461	0.00139	CcSEcCtD
Indacaterol—Pruritus—Risedronate—osteoporosis	0.000456	0.00138	CcSEcCtD
Indacaterol—Nausea—Calcitriol—osteoporosis	0.000454	0.00137	CcSEcCtD
Indacaterol—Hypersensitivity—Pamidronate—osteoporosis	0.000451	0.00136	CcSEcCtD
Indacaterol—Chest pain—Estradiol—osteoporosis	0.000449	0.00136	CcSEcCtD
Indacaterol—Myalgia—Estradiol—osteoporosis	0.000449	0.00136	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000446	0.00135	CcSEcCtD
Indacaterol—Dry mouth—Estradiol—osteoporosis	0.00044	0.00133	CcSEcCtD
Indacaterol—Dizziness—Ethinyl Estradiol—osteoporosis	0.000437	0.00132	CcSEcCtD
Indacaterol—Pruritus—Pamidronate—osteoporosis	0.000433	0.00131	CcSEcCtD
Indacaterol—Infection—Estradiol—osteoporosis	0.000428	0.0013	CcSEcCtD
Indacaterol—Dizziness—Risedronate—osteoporosis	0.000426	0.00129	CcSEcCtD
Indacaterol—Nervous system disorder—Estradiol—osteoporosis	0.000423	0.00128	CcSEcCtD
Indacaterol—Tachycardia—Estradiol—osteoporosis	0.000421	0.00127	CcSEcCtD
Indacaterol—Skin disorder—Estradiol—osteoporosis	0.000419	0.00127	CcSEcCtD
Indacaterol—Rash—Ethinyl Estradiol—osteoporosis	0.000416	0.00126	CcSEcCtD
Indacaterol—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000416	0.00126	CcSEcCtD
Indacaterol—Headache—Ethinyl Estradiol—osteoporosis	0.000414	0.00125	CcSEcCtD
Indacaterol—Hypersensitivity—Zoledronate—osteoporosis	0.000412	0.00125	CcSEcCtD
Indacaterol—Rash—Risedronate—osteoporosis	0.000406	0.00123	CcSEcCtD
Indacaterol—Dermatitis—Risedronate—osteoporosis	0.000406	0.00123	CcSEcCtD
Indacaterol—Dizziness—Pamidronate—osteoporosis	0.000405	0.00122	CcSEcCtD
Indacaterol—Headache—Risedronate—osteoporosis	0.000403	0.00122	CcSEcCtD
Indacaterol—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000397	0.0012	CcSEcCtD
Indacaterol—Pruritus—Zoledronate—osteoporosis	0.000396	0.0012	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000393	0.00119	CcSEcCtD
Indacaterol—Nausea—Ethinyl Estradiol—osteoporosis	0.000392	0.00119	CcSEcCtD
Indacaterol—Paraesthesia—Estradiol—osteoporosis	0.000387	0.00117	CcSEcCtD
Indacaterol—Rash—Pamidronate—osteoporosis	0.000386	0.00117	CcSEcCtD
Indacaterol—Dermatitis—Pamidronate—osteoporosis	0.000386	0.00117	CcSEcCtD
Indacaterol—Dyspnoea—Estradiol—osteoporosis	0.000384	0.00116	CcSEcCtD
Indacaterol—Headache—Pamidronate—osteoporosis	0.000383	0.00116	CcSEcCtD
Indacaterol—Nausea—Risedronate—osteoporosis	0.000382	0.00116	CcSEcCtD
Indacaterol—Pruritus—Conjugated Estrogens—osteoporosis	0.000381	0.00115	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Estradiol—osteoporosis	0.000372	0.00113	CcSEcCtD
Indacaterol—Dizziness—Zoledronate—osteoporosis	0.00037	0.00112	CcSEcCtD
Indacaterol—Nausea—Pamidronate—osteoporosis	0.000364	0.0011	CcSEcCtD
Indacaterol—Dizziness—Conjugated Estrogens—osteoporosis	0.000356	0.00108	CcSEcCtD
Indacaterol—Rash—Zoledronate—osteoporosis	0.000353	0.00107	CcSEcCtD
Indacaterol—Dermatitis—Zoledronate—osteoporosis	0.000352	0.00107	CcSEcCtD
Indacaterol—Headache—Zoledronate—osteoporosis	0.00035	0.00106	CcSEcCtD
Indacaterol—Rash—Conjugated Estrogens—osteoporosis	0.000339	0.00103	CcSEcCtD
Indacaterol—Dermatitis—Conjugated Estrogens—osteoporosis	0.000339	0.00103	CcSEcCtD
Indacaterol—Headache—Conjugated Estrogens—osteoporosis	0.000337	0.00102	CcSEcCtD
Indacaterol—Nausea—Zoledronate—osteoporosis	0.000332	0.001	CcSEcCtD
Indacaterol—Nausea—Conjugated Estrogens—osteoporosis	0.00032	0.000968	CcSEcCtD
Indacaterol—Hypersensitivity—Estradiol—osteoporosis	0.000317	0.000961	CcSEcCtD
Indacaterol—Pruritus—Estradiol—osteoporosis	0.000305	0.000922	CcSEcCtD
Indacaterol—Dizziness—Estradiol—osteoporosis	0.000285	0.000862	CcSEcCtD
Indacaterol—Rash—Estradiol—osteoporosis	0.000272	0.000822	CcSEcCtD
Indacaterol—Dermatitis—Estradiol—osteoporosis	0.000271	0.000821	CcSEcCtD
Indacaterol—Headache—Estradiol—osteoporosis	0.00027	0.000817	CcSEcCtD
Indacaterol—Nausea—Estradiol—osteoporosis	0.000256	0.000774	CcSEcCtD
Indacaterol—ADRB2—G alpha (s) signalling events—CALCA—osteoporosis	2.52e-05	0.00853	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	2.5e-05	0.00848	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	2.44e-05	0.00827	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CALCR—osteoporosis	2.44e-05	0.00826	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—PTH1R—osteoporosis	2.44e-05	0.00826	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	2.41e-05	0.00818	CbGpPWpGaD
Indacaterol—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	2.41e-05	0.00816	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—PTH1R—osteoporosis	2.38e-05	0.00808	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CALCR—osteoporosis	2.38e-05	0.00808	CbGpPWpGaD
Indacaterol—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	2.3e-05	0.0078	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	1.98e-05	0.00671	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—CYP19A1—osteoporosis	1.95e-05	0.00662	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	1.94e-05	0.00659	CbGpPWpGaD
Indacaterol—UGT1A1—Metapathway biotransformation—CYP19A1—osteoporosis	1.93e-05	0.00653	CbGpPWpGaD
Indacaterol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	1.91e-05	0.00648	CbGpPWpGaD
Indacaterol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—osteoporosis	1.87e-05	0.00634	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—ADCY5—osteoporosis	1.83e-05	0.0062	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—AGER—osteoporosis	1.83e-05	0.00619	CbGpPWpGaD
Indacaterol—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.81e-05	0.00615	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—ADCY5—osteoporosis	1.79e-05	0.00607	CbGpPWpGaD
Indacaterol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	1.76e-05	0.00598	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.64e-05	0.00555	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—osteoporosis	1.6e-05	0.00543	CbGpPWpGaD
Indacaterol—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	1.58e-05	0.00538	CbGpPWpGaD
Indacaterol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	1.58e-05	0.00536	CbGpPWpGaD
Indacaterol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—osteoporosis	1.54e-05	0.00524	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CALCR—osteoporosis	1.38e-05	0.00467	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PTH1R—osteoporosis	1.38e-05	0.00467	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	1.35e-05	0.00457	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PTH1R—osteoporosis	1.35e-05	0.00457	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CALCR—osteoporosis	1.35e-05	0.00457	CbGpPWpGaD
Indacaterol—ADRB1—G alpha (s) signalling events—POMC—osteoporosis	1.35e-05	0.00456	CbGpPWpGaD
Indacaterol—ADRB2—G alpha (s) signalling events—POMC—osteoporosis	1.32e-05	0.00446	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	1.28e-05	0.00435	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—PTH—osteoporosis	1.28e-05	0.00434	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	1.27e-05	0.00432	CbGpPWpGaD
Indacaterol—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	1.26e-05	0.00429	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—PTH—osteoporosis	1.25e-05	0.00425	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PTH1R—osteoporosis	1.25e-05	0.00424	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CALCR—osteoporosis	1.25e-05	0.00424	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CNR2—osteoporosis	1.25e-05	0.00423	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTH1R—osteoporosis	1.22e-05	0.00415	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CALCR—osteoporosis	1.22e-05	0.00415	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CNR2—osteoporosis	1.22e-05	0.00414	CbGpPWpGaD
Indacaterol—UGT1A1—Biological oxidations—POMC—osteoporosis	1.17e-05	0.00398	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—WNT1—osteoporosis	1.17e-05	0.00398	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—WNT1—osteoporosis	1.15e-05	0.00389	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PKM—osteoporosis	1.11e-05	0.00375	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—FDPS—osteoporosis	1.11e-05	0.00375	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—MGLL—osteoporosis	1.09e-05	0.00371	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—MGLL—osteoporosis	1.07e-05	0.00363	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—PTHLH—osteoporosis	1.06e-05	0.0036	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.05e-05	0.00356	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GPD2—osteoporosis	1.05e-05	0.00356	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PGLS—osteoporosis	1.05e-05	0.00356	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.04e-05	0.00352	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—PTHLH—osteoporosis	1.04e-05	0.00352	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.04e-05	0.00351	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MGLL—osteoporosis	9.93e-06	0.00337	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MGLL—osteoporosis	9.72e-06	0.00329	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PNP—osteoporosis	9.6e-06	0.00325	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ATIC—osteoporosis	9.6e-06	0.00325	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—CALCA—osteoporosis	9.34e-06	0.00317	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—CALCA—osteoporosis	9.13e-06	0.0031	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	9.07e-06	0.00308	CbGpPWpGaD
Indacaterol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	8.5e-06	0.00288	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SOST—osteoporosis	8.17e-06	0.00277	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CA2—osteoporosis	8.16e-06	0.00277	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—OXCT1—osteoporosis	8.16e-06	0.00277	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SOST—osteoporosis	7.99e-06	0.00271	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MGLL—osteoporosis	7.95e-06	0.0027	CbGpPWpGaD
Indacaterol—UGT1A1—NRF2 pathway—TGFB1—osteoporosis	7.71e-06	0.00262	CbGpPWpGaD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	7.7e-06	0.00261	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL1B—osteoporosis	7.44e-06	0.00252	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTH1R—osteoporosis	7.39e-06	0.0025	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CALCR—osteoporosis	7.39e-06	0.0025	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PTH—osteoporosis	7.23e-06	0.00245	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CALCR—osteoporosis	7.22e-06	0.00245	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTH1R—osteoporosis	7.22e-06	0.00245	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	7.12e-06	0.00242	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PTH—osteoporosis	7.07e-06	0.0024	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CNR2—osteoporosis	7.05e-06	0.00239	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CNR2—osteoporosis	6.89e-06	0.00234	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—IDH2—osteoporosis	6.76e-06	0.00229	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PTH—osteoporosis	6.57e-06	0.00223	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTH—osteoporosis	6.42e-06	0.00218	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.41e-06	0.00218	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CNR2—osteoporosis	6.4e-06	0.00217	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP27A1—osteoporosis	6.36e-06	0.00216	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	6.27e-06	0.00213	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CNR2—osteoporosis	6.26e-06	0.00212	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.24e-06	0.00212	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ACP5—osteoporosis	6.18e-06	0.0021	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—WNT1—osteoporosis	6.02e-06	0.00204	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PTHLH—osteoporosis	5.99e-06	0.00203	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—WNT1—osteoporosis	5.89e-06	0.002	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MGLL—osteoporosis	5.87e-06	0.00199	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PTHLH—osteoporosis	5.86e-06	0.00199	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TGFB1—osteoporosis	5.78e-06	0.00196	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—TPI1—osteoporosis	5.75e-06	0.00195	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MGLL—osteoporosis	5.74e-06	0.00195	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LRP5—osteoporosis	5.73e-06	0.00194	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LRP5—osteoporosis	5.6e-06	0.0019	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	5.52e-06	0.00187	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	5.5e-06	0.00187	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LRP6—osteoporosis	5.48e-06	0.00186	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	5.44e-06	0.00185	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PTHLH—osteoporosis	5.44e-06	0.00185	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—P4HB—osteoporosis	5.4e-06	0.00183	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—TNF—osteoporosis	5.4e-06	0.00183	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LRP6—osteoporosis	5.36e-06	0.00182	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PTHLH—osteoporosis	5.32e-06	0.00181	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GAPDH—osteoporosis	5.31e-06	0.0018	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—CALCA—osteoporosis	5.28e-06	0.00179	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—RAP1A—osteoporosis	5.17e-06	0.00175	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—CALCA—osteoporosis	5.16e-06	0.00175	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—FDPS—osteoporosis	5.08e-06	0.00172	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PKM—osteoporosis	5.08e-06	0.00172	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—POMC—osteoporosis	4.88e-06	0.00166	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPD2—osteoporosis	4.81e-06	0.00163	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PGLS—osteoporosis	4.81e-06	0.00163	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—CALCA—osteoporosis	4.79e-06	0.00162	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—POMC—osteoporosis	4.78e-06	0.00162	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	4.76e-06	0.00161	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—CALCA—osteoporosis	4.69e-06	0.00159	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TLN1—osteoporosis	4.62e-06	0.00157	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TLN1—osteoporosis	4.52e-06	0.00153	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ATIC—osteoporosis	4.4e-06	0.00149	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PNP—osteoporosis	4.4e-06	0.00149	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ENO1—osteoporosis	4.18e-06	0.00142	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PSMA2—osteoporosis	4.12e-06	0.0014	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PSMA5—osteoporosis	4.12e-06	0.0014	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—P4HB—osteoporosis	3.99e-06	0.00135	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—P4HB—osteoporosis	3.9e-06	0.00132	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTH—osteoporosis	3.88e-06	0.00132	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAP1A—osteoporosis	3.81e-06	0.00129	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTH—osteoporosis	3.79e-06	0.00129	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CNR2—osteoporosis	3.78e-06	0.00128	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ADCY5—osteoporosis	3.75e-06	0.00127	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—OXCT1—osteoporosis	3.74e-06	0.00127	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CA2—osteoporosis	3.74e-06	0.00127	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAP1A—osteoporosis	3.73e-06	0.00126	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—NFATC1—osteoporosis	3.72e-06	0.00126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CNR2—osteoporosis	3.7e-06	0.00125	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—DKK1—osteoporosis	3.69e-06	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—ADCY5—osteoporosis	3.67e-06	0.00124	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MGLL—osteoporosis	3.65e-06	0.00124	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—NFATC1—osteoporosis	3.64e-06	0.00123	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—DKK1—osteoporosis	3.61e-06	0.00122	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—WNT1—osteoporosis	3.55e-06	0.00121	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—WNT1—osteoporosis	3.48e-06	0.00118	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGA—osteoporosis	3.46e-06	0.00117	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ADCY5—osteoporosis	3.41e-06	0.00116	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGA—osteoporosis	3.38e-06	0.00115	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP19A1—osteoporosis	3.34e-06	0.00113	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—ADCY5—osteoporosis	3.33e-06	0.00113	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—POMC—osteoporosis	3.32e-06	0.00112	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTHLH—osteoporosis	3.21e-06	0.00109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BMP2—osteoporosis	3.21e-06	0.00109	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FGB—osteoporosis	3.15e-06	0.00107	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTHLH—osteoporosis	3.14e-06	0.00107	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BMP2—osteoporosis	3.14e-06	0.00107	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PKM—osteoporosis	3.13e-06	0.00106	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FDPS—osteoporosis	3.13e-06	0.00106	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—IDH2—osteoporosis	3.1e-06	0.00105	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FGB—osteoporosis	3.08e-06	0.00104	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PSMA5—osteoporosis	3.04e-06	0.00103	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PSMA2—osteoporosis	3.04e-06	0.00103	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PSMA2—osteoporosis	2.97e-06	0.00101	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PSMA5—osteoporosis	2.97e-06	0.00101	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PGLS—osteoporosis	2.97e-06	0.00101	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPD2—osteoporosis	2.97e-06	0.00101	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP27A1—osteoporosis	2.92e-06	0.000989	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	2.86e-06	0.00097	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	2.85e-06	0.000968	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ACP5—osteoporosis	2.84e-06	0.000962	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CALCA—osteoporosis	2.83e-06	0.00096	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CALCA—osteoporosis	2.77e-06	0.000939	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—POMC—osteoporosis	2.76e-06	0.000936	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ADCY5—osteoporosis	2.73e-06	0.000925	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GPX1—osteoporosis	2.72e-06	0.000922	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ATIC—osteoporosis	2.71e-06	0.00092	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PNP—osteoporosis	2.71e-06	0.00092	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—POMC—osteoporosis	2.7e-06	0.000916	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	2.67e-06	0.000906	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	2.67e-06	0.000904	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—TPI1—osteoporosis	2.64e-06	0.000894	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KL—osteoporosis	2.57e-06	0.000872	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KL—osteoporosis	2.51e-06	0.000853	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—MTHFR—osteoporosis	2.51e-06	0.000851	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—POMC—osteoporosis	2.51e-06	0.00085	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—P4HB—osteoporosis	2.48e-06	0.000841	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—POMC—osteoporosis	2.45e-06	0.000832	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6R—osteoporosis	2.45e-06	0.000829	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GAPDH—osteoporosis	2.43e-06	0.000825	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6R—osteoporosis	2.39e-06	0.000811	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—RAP1A—osteoporosis	2.37e-06	0.000804	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—OXCT1—osteoporosis	2.31e-06	0.000782	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA2—osteoporosis	2.31e-06	0.000782	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MGLL—osteoporosis	2.25e-06	0.000762	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ADCY5—osteoporosis	2.01e-06	0.000683	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—POMC—osteoporosis	2.01e-06	0.000681	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ADCY5—osteoporosis	1.97e-06	0.000668	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SPP1—osteoporosis	1.95e-06	0.00066	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ENO1—osteoporosis	1.92e-06	0.00065	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—IDH2—osteoporosis	1.91e-06	0.000648	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SPP1—osteoporosis	1.91e-06	0.000646	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PSMA2—osteoporosis	1.89e-06	0.00064	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PSMA5—osteoporosis	1.89e-06	0.00064	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.8e-06	0.000609	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IRS2—osteoporosis	1.76e-06	0.000597	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ACP5—osteoporosis	1.75e-06	0.000593	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—LEP—osteoporosis	1.72e-06	0.000585	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IRS2—osteoporosis	1.72e-06	0.000584	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—LEP—osteoporosis	1.69e-06	0.000572	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ESR1—osteoporosis	1.65e-06	0.000558	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—TPI1—osteoporosis	1.62e-06	0.000551	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ESR1—osteoporosis	1.61e-06	0.000546	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IRS1—osteoporosis	1.54e-06	0.000521	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP19A1—osteoporosis	1.53e-06	0.000519	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—P4HB—osteoporosis	1.53e-06	0.000518	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IRS1—osteoporosis	1.5e-06	0.00051	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GAPDH—osteoporosis	1.5e-06	0.000508	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—POMC—osteoporosis	1.48e-06	0.000502	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—RAP1A—osteoporosis	1.46e-06	0.000495	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—POMC—osteoporosis	1.45e-06	0.000491	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6R—osteoporosis	1.44e-06	0.00049	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1—osteoporosis	1.42e-06	0.000483	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6R—osteoporosis	1.41e-06	0.000479	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1—osteoporosis	1.39e-06	0.000472	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ADCY5—osteoporosis	1.25e-06	0.000424	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPX1—osteoporosis	1.25e-06	0.000423	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ENO1—osteoporosis	1.18e-06	0.0004	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PSMA2—osteoporosis	1.16e-06	0.000394	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PSMA5—osteoporosis	1.16e-06	0.000394	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—MTHFR—osteoporosis	1.15e-06	0.00039	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL6—osteoporosis	1.09e-06	0.000369	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL6—osteoporosis	1.07e-06	0.000361	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP19A1—osteoporosis	9.44e-07	0.00032	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—POMC—osteoporosis	9.21e-07	0.000312	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—osteoporosis	8.56e-07	0.00029	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TGFB1—osteoporosis	8.54e-07	0.00029	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—osteoporosis	8.37e-07	0.000284	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TGFB1—osteoporosis	8.35e-07	0.000283	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ADCY5—osteoporosis	7.71e-07	0.000261	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPX1—osteoporosis	7.68e-07	0.000261	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—MTHFR—osteoporosis	7.09e-07	0.000241	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL6—osteoporosis	6.43e-07	0.000218	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL6—osteoporosis	6.29e-07	0.000213	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—POMC—osteoporosis	5.67e-07	0.000192	CbGpPWpGaD
